EUVIMEDEUVIMED entdecken
Open Access

Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin–expressing cancers

Shani Koshrovski-Michael iD, Daniel Rodriguez Ajamil iD, Pradip Dey iD, Ron Kleiner iD, Shahar Tevet iD, Yana Epshtein, Marina Green Buzhor, Rami Khoury, Sabina Pozzi iD, Gal Shenbach-Koltin, Eilam Yeini, Laura Woythe iD und 8 weitere

Science Advances · 13.12.2024 · 10 (50)

DOI: 10.1126/sciadv.adr4762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 13.12.2024. Verfasst von Shani Koshrovski-Michael und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel. Hauptthemen laut MEDLINE: P-Selectin, Nanoparticles, Polyethylene Glycols. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combined therapies in cancer treatment aim to enhance antitumor activity. However, delivering multiple small molecules imposes challenges, as different drugs have distinct pharmacokinetic profiles and tumor penetration abilities, affecting their therapeutic efficacy. To circumvent this, poly(lactic-co-glycolic acid) (PLGA)–polyethylene glycol (PEG)–based nanoparticles were developed as a platform for the codelivery of synergistic drug ratios, improving therapeutic efficacy by increasing the percentage of injected dose reaching the tumor. Nonetheless, extravasation-dependent tumor accumulation is susceptible to variations in tumor vasculature; therefore, PLGA-PEG was modified with sulfates to actively target P-selectin–expressing cancers. Here, we show the potential of our platform in unique three-dimensional (3D) in vitro and in vivo models. The P-selectin–targeted nanoparticles showed enhanced accumulation in 3D spheroids and tissues of P-selectin–expressing BRAF-mutated melanomas and BRCA-mutated breast cancers, resulting in superior in vivo efficacy and safety. This nanoplatform could advance the codelivery of a plethora of anticancer drug combinations to various P-selectin–expressing tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

P-SelectinNanoparticlesPolyethylene GlycolsAnimalsHumansMiceCell Line, TumorAntineoplastic AgentsFemaleNeoplasmsXenograft Model Antitumor AssaysDrug CarriersPolylactic Acid-Polyglycolic Acid Copolymer

Substanzen

P-SelectinPolyethylene GlycolsAntineoplastic AgentsDrug CarriersPolylactic Acid-Polyglycolic Acid Copolymer

Autor:innen und Institutionen

  • Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Department of Chemistry, Siksha Bhavana, Visva-Bharati University, Santiniketan, West Bengal 731235, India.
  • The Center for Physics and Chemistry of Living Systems, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Department of Organic Chemistry, School of Chemistry, Faculty of Exact Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Tel Aviv University Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv 6997801, Israel.
  • ADAMA Center for Novel Delivery Systems in Crop Protection, Tel Aviv University, Tel Aviv 6997801, Israel.

ORCID-Profile: Shani Koshrovski-Michael, Daniel Rodriguez Ajamil, Pradip Dey, Ron Kleiner, Shahar Tevet, Sabina Pozzi, Laura Woythe, Rachel Blau, Anna Scomparin, Helena F Florindo, Shlomi Lazar, Roey J Amir, Ronit Satchi-Fainaro

Förderung

  • European Research Council

Zitieren

APA

Koshrovski-Michael, S., Ajamil, D. R., Dey, P., Kleiner, R., Tevet, S., Epshtein, Y., Green Buzhor, M., Khoury, R., Pozzi, S., Shenbach-Koltin, G., Yeini, E., Woythe, L., Blau, R., Scomparin, A., Barshack, I., Florindo, H. F., Lazar, S., Albertazzi, L., Amir, R. J., & Satchi-Fainaro, R. (2024). Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin–expressing cancers. Science Advances, 10(50). https://doi.org/10.1126/sciadv.adr4762

Vancouver

Koshrovski-Michael S, Ajamil DR, Dey P, Kleiner R, Tevet S, Epshtein Y, et al. Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin–expressing cancers. Science Advances. 2024;10(50). doi:10.1126/sciadv.adr4762

BibTeX
@article{KoshrovskiMichael2024,
  author = {Koshrovski-Michael, Shani and Ajamil, Daniel Rodriguez and Dey, Pradip and Kleiner, Ron and Tevet, Shahar and Epshtein, Yana and Green Buzhor, Marina and Khoury, Rami and Pozzi, Sabina and Shenbach-Koltin, Gal and Yeini, Eilam and Woythe, Laura and Blau, Rachel and Scomparin, Anna and Barshack, Iris and Florindo, Helena F and Lazar, Shlomi and Albertazzi, Lorenzo and Amir, Roey J and Satchi-Fainaro, Ronit},
  title = {Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin–expressing cancers},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {50},
  doi = {10.1126/sciadv.adr4762}
}
Kostenlos starten →